Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Trials|July 6, 2013
Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)Martina Gaggl, Daniel Cejka, Max Plischke, et al.
Kidney International Reports|June 20, 2024
Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients - The CitMag StudyDaniel Cejka, Ursula Thiem, Eric Blinzler, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2023) : Common guideline of the Austrian Society for Bone and Mineral Research and the Austrian Diabetes Society]Christian Muschitz, Alexandra Kautzky-Willer, Yvonne Winhofer, et al.
European Surgery : ACA : Acta Chirurgica Austriaca|October 19, 2022
Coping with a lack of evidence: living-donor kidney transplantation in the initial phase of the SARS-CoV-2 pandemicNadina Roth, Christiane Sophie Rösch, Axel Krause, et al.
Cancer Letters|May 18, 2010
mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivoThorsten Fuereder, Agnes Jaeger-Lansky, Doris Hoeflmayer, et al.
International Journal of Molecular Sciences|November 27, 2025
Molecular Diagnostics Supporting a ≥35% Diffuse Peritubular Capillaritis Extent Threshold for Diagnosis of AMR-A Retrospective Dual Center StudyMichael Eder, Marian C Clahsen-van Groningen, Michael Mengel, et al.
Frontiers in Transplantation|December 23, 2024
Vascular reconstructions in living donor kidney transplantation: a single-center experience over the last 17 yearsNadina Roth, Manfred Kalteis, Axel Krause, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2010
Sclerostin and Dickkopf-1 in renal osteodystrophyDaniel Cejka, Johann Herberth, Adam J Branscum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2022
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cellsUrsula Thiem, Tim D Hewitson, Nigel D Toussaint, et al.
Clinical Kidney Journal|February 24, 2021
The effect of phosphate binder therapy with sucroferric oxyhydroxide on calcification propensity in chronic haemodialysis patients: a randomized, controlled, crossover trialUrsula Thiem, Ina Soellradl, Bernhard Robl, et al.
Pageof 7